Display options
Cite
An KY, Shin WJ, Lee KJ. The necessity of bone densitometry for patients taking selective serotonin reuptake inhibitors. J Bone Metab. 2013;20(2):95-8doi: 10.11005/jbm.2013.20.2.95.
An, K. Y., Shin, W. J., & Lee, K. J. (2013). The necessity of bone densitometry for patients taking selective serotonin reuptake inhibitors. Journal of bone metabolism, 20(2), 95-8. https://doi.org/10.11005/jbm.2013.20.2.95
An, Ki-Yong, et al. "The necessity of bone densitometry for patients taking selective serotonin reuptake inhibitors." Journal of bone metabolism vol. 20,2 (2013): 95-8. doi: https://doi.org/10.11005/jbm.2013.20.2.95
An KY, Shin WJ, Lee KJ. The necessity of bone densitometry for patients taking selective serotonin reuptake inhibitors. J Bone Metab. 2013 Nov;20(2):95-8. doi: 10.11005/jbm.2013.20.2.95. Epub 2013 Nov 18. PMID: 24524064; PMCID: PMC3910306.
Copy Download .nbib Format: NLM
Share it on

J Bone Metab. 2013 Nov;20(2):95-8. doi: 10.11005/jbm.2013.20.2.95. Epub 2013 Nov 18.

The necessity of bone densitometry for patients taking selective serotonin reuptake inhibitors.

Journal of bone metabolism

Ki-Yong An, Woo-Jin Shin, Kyu-Jung Lee

Affiliations

  1. Department of Orthopedic Surgery, Gwangju Veterans Hospital, Gwangju, Korea.

PMID: 24524064 PMCID: PMC3910306 DOI: 10.11005/jbm.2013.20.2.95

Abstract

BACKGROUND: To analyze the necessity of bone densitometry for patients long-term taking selective serotonin reuptake inhibitors (SSRI) over a long period of time, which is one of the risk factors of osteoporosis.

METHODS: We selected patients from 5 veterans hospitals who took SSRI for more than 2 months while taking bone densitometry on a regular basis.

RESULTS: Of the 85 patients from a total of 5 veterans hospitals taking SSRI for more than two months, only 34 patients were under diagnosis and treatment measures of osteoporosis through checking each person's bone mineral density.

CONCLUSIONS: It is necessary for patients taking SSRI to check bone density on a regular basis.

Keywords: Osteoporosis; Prevalence; Serotonin uptake inhibitors

References

  1. Biol Psychiatry. 2009 Sep 1;66(5):423-32 - PubMed
  2. BMJ. 1995 Jun 3;310(6992):1433-8 - PubMed
  3. Cochrane Database Syst Rev. 2000;(4):CD002791 - PubMed
  4. BMJ. 2003 May 10;326(7397):1014 - PubMed
  5. Prog Neuropsychopharmacol Biol Psychiatry. 2003 Feb;27(1):85-102 - PubMed
  6. Cell. 2008 Nov 28;135(5):825-37 - PubMed
  7. J Psychiatr Res. 2006 Feb;40(1):30-6 - PubMed
  8. J Clin Epidemiol. 1997 Mar;50(3):313-20 - PubMed
  9. Arch Intern Med. 2007 Jun 25;167(12):1246-51 - PubMed
  10. Stroke. 1999 Sep;30(9):1949-54 - PubMed
  11. Br J Pharmacol. 1999 Jun;127(3):740-6 - PubMed
  12. Arch Intern Med. 2007 Jan 22;167(2):188-94 - PubMed
  13. JAMA. 1990 Feb 2;263(5):665-8 - PubMed

Publication Types